Revlimid (Lenalidomide) 25mg


Revlimid is an immunomodulatory drug related to thalidomide. It boosts immune function by stimulating T-cell and natural killer cell activity. In addition, it inhibits the growth of cancer cells and blocks development of blood vessels that feed tumors.

Clinical trials showed that Revlimid plus dexamethasone slows progression of multiple myeloma and mantle cell lymphoma. It is also being studied for diffuse large B-cell lymphoma. Revlimid was first approved in 2005.



Side Effects

Common side effects include fatigue, diarrhea, constipation, muscle and back pain, fever, swelling, insomnia and neuropathy (nerve damage). It can cause depletion of red blood cells (anemia), white blood cells (neutropenia) and platelets (thrombocytopenia), which can lead to infections and easy bleeding. Potential serious side effects include deep vein thrombosis (blood clots), pulmonary embolism, heart attack, stroke, liver problems, severe skin reactions and tumor lysis syndrome (metabolic abnormalities that can occur when many cancer cells are killed at once). Like thalidomide, Revlimid can cause severe birth defects and should not be used by pregnant women or those who could become pregnant.

Buy Revlimid (Lenalidomide) 25mg online is an oral anti-cancer medication. Lenalidomide is similar to thalidomide (Thalomid), an older cancer medicine that, although effective, was associated with serious side effects. The exact mechanism through which lenalidomide stops the growth of cancer cells is not understood. Lenalidomide stimulates or regulates the body’s immune system to attack and kill cancer cells, reduces the formation of new blood vessels that supply nutrients to the cancer cells, and prevents or stops growth of the cancer. Laboratory studies have shown that lenalidomide inhibits cancer growth and causes programmed cell death in certain types of cancers, including multiple myeloma, mantle cell lymphoma, and del (5q) myelodysplastic syndromes. Lenalidomide was approved by the FDA Dec. 27, 2005.

Dosage for lenalidomide Revlimid.

Your doctor will tell you how much Revlimid to take and for how long you will need to take it.

For the treatment of NDMM after a stem cell transplant, the usual starting dose is 10 mg once daily.

For the treatment of MM in combination with dexamethasone (either NDMM in patients not eligible for stem cell transplantion or MM in patients whose disease has progressed after one therapy), the usual starting dose is 25 mg once per day for 21 out of 28 days.

For the treatment of MDS, the recommended starting dose is 10 mg once per day for 21 out of 28 days.

For the treatment for MCL, the usual starting dose is 25 mg once per day for 21 out of 28 days.

Your doctor will monitor your progress, and may adjust your dose of Revlimid or stop your treatment based on the results of your blood tests and on your general condition.

How to take it:

Swallow the capsules whole, preferably with water, once a day as directed by your doctor.
Do not open, break or chew the capsules.
If powder from inside the capsules leaks out and contacts the skin, wash the skin immediately and thoroughly with soap and water. If lenalidomide contacts the mucous membranes e.g. the eyes, flush thoroughly with water.

When to take it:

Take your medicine either one hour before or two hours after eating food.

How long to take it:

Your doctor will tell you how long to continue taking Revlimid.
Continue taking Revlimid at about the same time each day for 21 days in a row and stop taking Revlimid for the next 7 days. Repeat taking Revlimid for 21 days and stopping for 7 days until your doctor tells you to stop.


There are no reviews yet.

Be the first to review “Revlimid (Lenalidomide) 25mg”

Your email address will not be published. Required fields are marked *